Unnamed: 0,title,date,stock,sentiment
1301950.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,UTHR,positive
1301951.0,Liquidia Issues Response To United Therapeutics Suit On Tyvaso Patents,2020-06-05 15:31:00-04:00,UTHR,positive
1301952.0,United Therapeutics Reports Filed Suit Against Liquidia Related To Infringement Of Tyvaso Patents,2020-06-05 06:07:00-04:00,UTHR,negative
1301953.0,United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents,2020-06-05 06:01:00-04:00,UTHR,negative
1301954.0,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",2020-06-04 08:13:00-04:00,UTHR,positive
1301955.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,UTHR,neutral
1301956.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-19 10:43:00-04:00,UTHR,neutral
1301957.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,UTHR,positive
1301958.0,Stocks That Hit 52-Week Highs On Monday,2020-05-18 10:44:00-04:00,UTHR,neutral
1301959.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,UTHR,neutral
1301960.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-12 10:41:00-04:00,UTHR,neutral
1301961.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,UTHR,positive
1301962.0,"United Therapeutics Q1 Adj. EPS $3.610 Beats $2.720 Estimate, Sales $356.300M Beat $344.330M Estimate",2020-04-29 06:09:00-04:00,UTHR,positive
1301963.0,"Earnings Scheduled For April 29, 2020",2020-04-29 04:50:00-04:00,UTHR,neutral
1301964.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,UTHR,negative
1301965.0,United Therapeutics Reports Added Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension,2020-04-23 06:07:00-04:00,UTHR,positive
1301966.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2020-03-31 17:15:00-04:00,UTHR,neutral
1301967.0,"Jefferies Upgrades United Therapeutics to Buy, Raises Price Target to $123",2020-03-10 05:14:00-04:00,UTHR,positive
1301968.0,"Cowen & Co. Upgrades United Therapeutics to Outperform, Raises Price Target to $145",2020-02-27 11:08:00-05:00,UTHR,positive
1301969.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,UTHR,negative
1301970.0,United Therapeutics shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results.,2020-02-26 09:16:00-05:00,UTHR,positive
1301971.0,A Peek Into The Markets: US Stock Futures Drop Ahead Of New-Home Sales Report,2020-02-26 06:29:00-05:00,UTHR,negative
1301972.0,"United Therapeutics Q4  Adj. EPS $1.96 Misses $2.65 Estimate, Sales $211M Miss $357.77M Estimate",2020-02-26 06:03:00-05:00,UTHR,positive
1301973.0,"Earnings Scheduled For February 26, 2020",2020-02-26 04:38:00-05:00,UTHR,neutral
1301974.0,United Therapeutics shares are trading higher after the company announced its study of Tyvaso met its primary and secondary endpoints. The company also announced FDA clearance related to its unity subcutaneous delivery system for remodulin.,2020-02-24 09:06:00-05:00,UTHR,positive
1301975.0,United Therapeutics Announces FDA Clearance of its Unity Subcutaneous Delivery System for Remodulin,2020-02-24 06:20:00-05:00,UTHR,positive
1301976.0,United Therapeutics' Clinical Study of Tyvaso Met its Primary and Secondary Endpoints,2020-02-24 06:11:00-05:00,UTHR,positive
1301977.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,UTHR,neutral
1301978.0,"Credit Suisse Maintains Outperform on United Therapeutics, Raises Price Target to $121",2020-02-13 08:28:00-05:00,UTHR,positive
1301979.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,UTHR,neutral
1301980.0,"United Therapeutics Reports Defeat Of Prelim. Injunction Motion In Litigation With Sandoz, RareGen",2020-02-04 17:05:00-05:00,UTHR,negative
1301981.0,United Therapeutics Study of Unituxin for Small Cell Lung Cancer Did Not Meet Primary Endpoint,2020-02-03 06:03:00-05:00,UTHR,negative
1301982.0,"JP Morgan Upgrades United Therapeutics to Overweight, Raises Price Target to $120",2020-01-31 06:56:00-05:00,UTHR,positive
1301983.0,United Therapeutics Shares Spike To Session High Hearing Sandoz Denied Request For Prelim Injunction Against CO.,2020-01-29 13:04:00-05:00,UTHR,positive
1301984.0,United Therapeutics 8-K Shows Co. Announced Delay In Potential Launch Of Implantable System For Remodulin From 2020 To 2021,2019-12-13 06:13:00-05:00,UTHR,positive
1301985.0,"Bank Of America Initiates United Therapeutics With Bearing Rating, Cites Unclear Growth Outlook",2019-12-03 14:43:00-05:00,UTHR,positive
1301986.0,MannKind Reports Receives Second $12.5M Milestone Payment From United Therapeutics,2019-11-04 09:00:00-05:00,UTHR,positive
1301987.0,22 Stocks Moving in Wednesday's Pre-Market Session,2019-10-30 07:15:00-04:00,UTHR,neutral
1301988.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,UTHR,negative
1301989.0,"United Therapeutics Q3 Adj. EPS $3.83 Down From $3.98 YoY, Sales $401.5M Down From $412.7M YoY",2019-10-30 06:09:00-04:00,UTHR,positive
1301990.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,UTHR,neutral
1301991.0,A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Earnings,2019-10-21 07:15:00-04:00,UTHR,neutral
1301992.0,United Therapeutics' Supplement to its New Drug Application for Orenitram is Accepted by the FDA,2019-10-21 06:28:00-04:00,UTHR,positive
1301993.0,United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study,2019-10-21 06:02:00-04:00,UTHR,positive
1301994.0,Respira Therapeutics Highlights Decision By United Therapeutics To Conclude Collaboration With Co. Cites 'strategic prioritization of assets within United Therapeutics' product development portfolio',2019-10-10 08:44:00-04:00,UTHR,positive
1301995.0,Correvio Reports FDA Accepted United Therapeutics' Trevyent New Drug Application,2019-09-12 07:12:00-04:00,UTHR,positive
1301996.0,United Therapeutics Announces FDA Acceptance Of Trevyent NDA For Review,2019-09-11 06:01:00-04:00,UTHR,positive
1301997.0,iBio Shares Rise 400% Premarket Following Announcement of Agreement with United Therapeutics to Produce Recombinant Human Collagen-based Bioink for 3D Bioprinted Organ Transplants,2019-08-20 06:55:00-04:00,UTHR,positive
1301998.0,iBio Enters Into Master Services Agreement With Lung Biotechnology For 3D Bioprinted Organ Transplants,2019-08-19 16:38:00-04:00,UTHR,positive
1301999.0,"Benzinga's Top Upgrades, Downgrades For August 1, 2019",2019-08-01 09:53:00-04:00,UTHR,positive
1302000.0,"Ladenburg Thalmann Upgrades United Therapeutics to Buy, Raises Price Target to $106",2019-08-01 07:38:00-04:00,UTHR,positive
1302001.0,"Jefferies Upgrades United Therapeutics to Hold, Announces $90 Price Target",2019-08-01 06:41:00-04:00,UTHR,positive
1302002.0,"United Therapeutics Earlier Reported Q2 Adj. EPS $3.63 Beats $2.49 Estimate, Sales $373.6M Beat $332.15M Estimate",2019-07-31 09:16:00-04:00,UTHR,positive
1302003.0,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster",2019-07-31 07:06:00-04:00,UTHR,negative
1302004.0,"Earnings Scheduled For July 31, 2019",2019-07-31 04:03:00-04:00,UTHR,neutral
1302005.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,UTHR,negative
1302006.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,UTHR,neutral
1302007.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,UTHR,negative
1302008.0,United Therapeutics Option Alert: Aug 16 $90 Calls at the Ask: 1471 @ $0.451 vs 106 OI; Earnings 7/31 Before Open [est] Ref=$75.57,2019-07-19 13:21:00-04:00,UTHR,positive
1302009.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,UTHR,positive
1302010.0,Credit Suisse: United Therapeutics Becoming More Fundamentally Driven,2019-07-01 14:37:00-04:00,UTHR,positive
1302011.0,United Therapeutics shares are trading higher after Credit Suisse upgraded the stock from Neutral to Outperform.,2019-07-01 09:47:00-04:00,UTHR,positive
1302012.0,"Benzinga's Top Upgrades, Downgrades For July 1, 2019",2019-07-01 09:14:00-04:00,UTHR,positive
1302013.0,Credit Suisse Upgrades United Therapeutics to Outperform,2019-07-01 07:01:00-04:00,UTHR,positive
1302014.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,UTHR,neutral
1302015.0,"The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix",2019-06-07 07:24:00-04:00,UTHR,positive
1302016.0,"The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut",2019-05-23 07:37:00-04:00,UTHR,neutral
1302017.0,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",2019-05-21 07:40:00-04:00,UTHR,negative
1302018.0,10 Biggest Price Target Changes For Friday,2019-05-17 09:37:00-04:00,UTHR,neutral
1302019.0,"Benzinga's Top Upgrades, Downgrades For May 17, 2019",2019-05-17 09:08:00-04:00,UTHR,positive
1302020.0,"UBS Upgrades United Therapeutics Corporation - Common Stock to Neutral, Lowers Price Target to $94",2019-05-17 06:50:00-04:00,UTHR,positive
1302021.0,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",2019-05-16 07:40:00-04:00,UTHR,neutral
1302022.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,UTHR,positive
1302023.0,"Benzinga's Top Upgrades, Downgrades For May 9, 2019",2019-05-09 09:07:00-04:00,UTHR,positive
1302024.0,Credit Suisse Upgrades United Therapeutics Corporation - Common Stock to Neutral,2019-05-09 07:42:00-04:00,UTHR,positive
1302025.0,United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin,2019-05-07 06:12:00-04:00,UTHR,positive
1302026.0,10 Biggest Price Target Changes For Thursday,2019-05-02 09:39:00-04:00,UTHR,neutral
1302027.0,"Wedbush Maintains Outperform on United Therapeutics Corporation - Common Stock, Raises Price Target to $273",2019-05-02 08:46:00-04:00,UTHR,positive
1302028.0,"The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue",2019-05-01 07:39:00-04:00,UTHR,neutral
1302029.0,"United Therapeutics Q1 EPS $3.58 May Not Compare to $2.78 Estimate, Sales $362.6M Beat $335.43M Estimate",2019-05-01 06:07:00-04:00,UTHR,positive
1302030.0,"Earnings Scheduled For May 1, 2019",2019-05-01 05:05:00-04:00,UTHR,neutral
1302031.0,Shares of several healthcare companies are trading lower on continued uncertainty over healthcare policy as well as concerns over the medicare-for-all proposals among 2020 candidates.,2019-04-30 12:16:00-04:00,UTHR,negative
1302032.0,United Therapeutics Announces FDA Approval Of XPS And Steen Solution Used To Perform Centralized Ex-Vivo Lung Perfusion Services,2019-04-29 06:20:00-04:00,UTHR,positive
1302033.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,UTHR,positive
1302034.0,United Therapeutics Says Lawsuit Filed by Sandoz and RareGen is 'Meritless',2019-04-18 04:33:00-04:00,UTHR,positive
1302035.0,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street,2019-04-08 07:32:00-04:00,UTHR,negative
1302036.0,UPDATE: United Therapeutics Says Will Discontinue Further Development Of Esuberaprost,2019-04-08 06:02:00-04:00,UTHR,positive
1302037.0,United Therapeutics Reports BEAT Study Of Esuberaprost Does Not Meet Primary Endpoint,2019-04-08 06:01:00-04:00,UTHR,positive
1302038.0,MannKind Receives $12.5M Milestone Payment from United Therapeutics,2019-04-01 06:03:00-04:00,UTHR,positive
1302039.0,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",2019-03-26 07:36:00-04:00,UTHR,positive
1302040.0,"Sandoz Has Exclusively Launched Generic Version Of United Therapeutics Remodulin, Treprostinil",2019-03-25 16:10:00-04:00,UTHR,positive
1302041.0,United Therapeutics Corporation To Present At Oppenheimer 29th Annual Healthcare Conference,2019-03-12 06:01:00-04:00,UTHR,positive
1302042.0,"Barclays Maintains Underweight on United Therapeutics, Lowers Price Target to $95",2019-03-01 10:14:00-05:00,UTHR,positive
1302043.0,"United Therapeutics Q4 Adj. EPS $3.34 Beats $2.55 Estimate, Sales $381.4M Beat $355.83M Estimate",2019-02-27 06:07:00-05:00,UTHR,positive
1302044.0,"Earnings Scheduled For February 27, 2019",2019-02-27 04:03:00-05:00,UTHR,neutral
1302045.0,31 Stocks Moving In Thursday's Pre-Market Session,2019-02-21 08:09:00-05:00,UTHR,neutral
1302046.0,"The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug",2019-01-25 07:38:00-05:00,UTHR,positive
1302047.0,Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag,2019-01-25 04:45:00-05:00,UTHR,positive
1302048.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-15 08:00:00-05:00,UTHR,neutral
1302049.0,United Therapeutics Reports Health Canada Approved Unituxin For Treatment Of Pediatric High-Risk Neuroblastoma,2018-11-29 16:30:00-05:00,UTHR,positive
1302050.0,"Credit Suisse Maintains Underperform on United Therapeutics, Raises Price Target to $105",2018-11-19 10:04:00-05:00,UTHR,positive
1302051.0,"UPDATE: Arena Will Grant United Therapeutics Exclusive Global Rights To Develop, Manufacture, Commercialize Ralinepag; Arena Will Receive Up To $1.2B",2018-11-15 07:02:00-05:00,UTHR,positive
1302052.0,"Arena Pharma, United Therapeutics Report Global License Deal For Ralinepag",2018-11-15 07:01:00-05:00,UTHR,positive
1302053.0,CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants,2018-11-12 06:03:00-05:00,UTHR,positive
1302054.0,"JP Morgan Maintains Neutral on United Therapeutics, Raises Price Target to $126",2018-11-02 12:57:00-04:00,UTHR,positive
1302055.0,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",2018-10-31 08:20:00-04:00,UTHR,negative
1302056.0,"United Therapeutics Corporation Q3 Adj. EPS $3.98 Beats $3.15 Estimate, Sales $412.7M Beat $381.27M Estimate",2018-10-31 06:11:00-04:00,UTHR,positive
1302057.0,"Earnings Scheduled For October 31, 2018",2018-10-31 04:06:00-04:00,UTHR,neutral
1302058.0,"10 Hottest Stocks From October 22, 2018",2018-10-22 16:55:00-04:00,UTHR,neutral
1302059.0,CollPlant Holdings shares are moving higher after announced a licensing agreement for 3D bioprinting of solid-organ scaffolds with United Therapeutics. CollPlant will receive $5M upfront and up to $15M in milestone payments.,2018-10-22 07:45:00-04:00,UTHR,positive
1302060.0,"CollPlant, United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants; CollPlant to Receive $5M Upfront, Up to $15M in Milestones",2018-10-22 04:13:00-04:00,UTHR,positive
1302061.0,Standpoint Research Upgrades United Therapeutics to Buy,2018-10-12 11:30:00-04:00,UTHR,positive
1302062.0,"Samumed, United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate; Deal Includes $10M Up-Front Plus Up To $340M In Developmental Milestones And Up To Low Double-Digit Royalties",2018-09-17 06:00:00-04:00,UTHR,positive
1302063.0,55 Biggest Movers From Yesterday,2018-09-05 04:48:00-04:00,UTHR,neutral
1302064.0,Mid-Afternoon Market Update: Gold Prices Fall Below $1200; MannKind Shares Spike Higher,2018-09-04 14:35:00-04:00,UTHR,positive
1302065.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-09-04 13:49:00-04:00,UTHR,neutral
1302066.0,Mid-Day Market Update: Ocean Rig Surges On Acquisition News; Seagate Shares Drop,2018-09-04 13:01:00-04:00,UTHR,negative
1302067.0,Benzinga Pro's 5 Stocks To Watch Today,2018-09-04 09:19:00-04:00,UTHR,neutral
1302068.0,A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Economic Data,2018-09-04 06:58:00-04:00,UTHR,negative
1302069.0,'I would have been more impressed had $UTHR $MNKD signed a deal to upload Al Mann's consciousness to the cloud.' -STAT's Adam Feuerstein Tweets (2/2),2018-09-04 06:40:00-04:00,UTHR,positive
1302070.0,"'$UTHR already sells an inhaled version of trespostinil. It's called Tyvaso. The molecule goes generic soon. Good luck, $MNKD.' -STAT's Adam Feuerstein Tweets (1/2)",2018-09-04 06:39:00-04:00,UTHR,positive
1302071.0,United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products; Mannkind Will Receive Upfront Payment of $45M And Potential Milestones Of Up To $50M,2018-09-04 06:02:00-04:00,UTHR,positive
1302072.0,United Therapeutics Announces Settlement of Patent Litigation With Watson Laboratories  Relating to Tyvaso,2018-08-08 20:08:00-04:00,UTHR,positive
1302073.0,40 Stocks Moving In Wednesday's Pre-Market Session,2018-08-08 08:08:00-04:00,UTHR,neutral
1302074.0,United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint,2018-08-08 06:06:00-04:00,UTHR,positive
1302075.0,"Wedbush Maintains Outperform on United Therapeutics, Raises Price Target to $253",2018-08-02 09:07:00-04:00,UTHR,positive
1302076.0,A Peek Into The Markets: US Stock Futures Mixed Ahead Of Fed Decision,2018-08-01 06:56:00-04:00,UTHR,neutral
1302077.0,"United Therapeutics Q2 Adj. EPS $4.36 Beats $3.16 Estimate, Sales $444.5M Beat $368.58M Estimate",2018-08-01 06:03:00-04:00,UTHR,positive
1302078.0,"Earnings Scheduled For August 1, 2018",2018-08-01 04:07:00-04:00,UTHR,neutral
1302079.0,United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin,2018-07-31 06:06:00-04:00,UTHR,positive
1302080.0,SteadyMed Shareholders Approve Proposed Acquisition By United Therapeutics; SteadyMed Shareholders To Be Entitled To Receive $4.46/Share In Cash And One Contractual Contingent Value Right Per Share,2018-07-31 06:05:00-04:00,UTHR,positive
1302081.0,"United Therapeutics, SteadyMed Report Termination Of Waiting Period Under Hart-Scott-Rodino Act",2018-07-20 06:01:00-04:00,UTHR,positive
1302082.0,"Credit Suisse Maintains Neutral on United Therapeutics, Raises Price Target to $107",2018-07-10 08:36:00-04:00,UTHR,positive
1302083.0,"United Therapeutics, XVIVO Perfusion Announce Collaboration to Reduce Organ Shortage Through Expansion of Organ Evaluation Service",2018-06-12 03:49:00-04:00,UTHR,positive
1302084.0,"Barclays Maintains Underweight on United Therapeutics, Lowers Price Target to $95.00",2018-05-03 13:14:00-04:00,UTHR,positive
1302085.0,"Credit Suisse Maintains Neutral on United Therapeutics, Lowers Price Target to $104.00",2018-05-03 11:09:00-04:00,UTHR,positive
1302086.0,United Therapeutics Reports Q1 2018  EPS of $3.76 vs $3.51 Est Revenue of $389.2M vs $396.11M Est,2018-05-02 06:11:00-04:00,UTHR,positive
1302087.0,"Earnings Scheduled For May 2, 2018",2018-05-02 05:54:00-04:00,UTHR,neutral
1302088.0,36 Biggest Movers From Yesterday,2018-05-01 05:02:00-04:00,UTHR,neutral
1302089.0,Merger Monday Makes A Return,2018-04-30 15:24:00-04:00,UTHR,neutral
1302090.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Financial Engines Shares Spike Higher,2018-04-30 14:19:00-04:00,UTHR,negative
1302091.0,36 Stocks Moving In Monday's Mid-Day Session,2018-04-30 13:16:00-04:00,UTHR,neutral
1302092.0,Mid-Day Market Update: SteadyMed Climbs Following Acquisition News; Cooper Tire & Rubber Shares Slide,2018-04-30 12:34:00-04:00,UTHR,positive
1302093.0,Mid-Morning Market Update: Markets Open Higher; Sprint And T-Mobile To Merge In $26 Billion Deal,2018-04-30 10:06:00-04:00,UTHR,neutral
1302094.0,26 Stocks Moving In Monday's Pre-Market Session,2018-04-30 08:07:00-04:00,UTHR,neutral
1302095.0,United Therapeutics to Acquire SteadyMed for $4.46/Share Cash and an Additional $2.63/Share Cash if a Milestone is Met,2018-04-30 06:05:00-04:00,UTHR,positive
1302096.0,United Therapeutics to Acquire Steadymed for $4.46/Share in Cash at Closing,2018-04-30 06:03:00-04:00,UTHR,positive
1302097.0,35 Biggest Movers From Yesterday,2018-04-04 04:20:00-04:00,UTHR,neutral
1302098.0,"United Therapeutics Has Limited Downside Below $95 Level, Credit Suisse Says In Upgrade",2018-04-03 16:05:00-04:00,UTHR,positive
1302099.0,26 Stocks Moving In Tuesday's Mid-Day Session,2018-04-03 12:29:00-04:00,UTHR,neutral
1302100.0,"Benzinga's Top Upgrades, Downgrades For April 3, 2018",2018-04-03 09:55:00-04:00,UTHR,positive
1302101.0,Credit Suisse Upgrades United Therapeutics to Neutral,2018-04-03 07:53:00-04:00,UTHR,positive
1302102.0,"Credit Suisse Maintains Underperform on United Therapeutics, Lowers price target to $115.00",2018-02-22 09:09:00-05:00,UTHR,positive
1302103.0,A Peek Into The Markets: U.S. Stock Futures Fall; All Eyes On Fed Minutes,2018-02-21 06:54:00-05:00,UTHR,neutral
1302104.0,"United Therapeutics Reports Q4 EPS $3.89 vs $3.89 Est., Sales $464.7M vs $421M Est.",2018-02-21 06:01:00-05:00,UTHR,positive
1302105.0,"Earnings Scheduled For February 21, 2018",2018-02-21 04:00:00-05:00,UTHR,neutral
1302106.0,"United Therapeutics Shares Appear Unaffected Fri. Following Late Thurs. News Of Settlement Of Patent Litigation With Actavis Related To Orenitram; Co. Granted Actavis License To Manufacture, Commercialize Generic Version",2018-02-16 09:37:00-05:00,UTHR,positive
1302107.0,A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Fed Minutes,2018-01-03 07:07:00-05:00,UTHR,neutral
1302108.0,"Corsair Pharma, United Therapeutics Enter Into Strategic Collaboration to Advance Novel Treprostinil Prodrugs",2018-01-03 06:02:00-05:00,UTHR,positive
1302109.0,5 Biggest Price Target Changes For Wednesday,2017-12-27 09:42:00-05:00,UTHR,neutral
1302110.0,United Therapeutics Has Settled US Kickback Investigation For $210M,2017-12-20 11:14:00-05:00,UTHR,positive
1302111.0,"United Therapeutics is Grated Pediatric Exclusivity for Adcirca Through May 21, 2018 by the FDA",2017-11-20 06:02:00-05:00,UTHR,positive
1302112.0,"United Therapeutics Q3 Adj. EPS $4.69 vs $3.87 Est., Sales $445.5M vs $426.4M Est.",2017-10-25 06:03:00-04:00,UTHR,positive
1302113.0,"Earnings Scheduled For October 25, 2017",2017-10-25 04:24:00-04:00,UTHR,neutral
1302114.0,United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso Inhalation System,2017-10-23 06:01:00-04:00,UTHR,positive
1302115.0,22 Biggest Mid-Day Losers For Friday,2017-09-08 13:39:00-04:00,UTHR,negative
1302116.0,Oppenheimer Presents New Menu Of Top Picks,2017-09-01 11:59:00-04:00,UTHR,positive
1302117.0,"Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",2017-08-07 07:19:00-04:00,UTHR,positive
1302118.0,"JP Morgan Out Negative On United Therapeutics, Says Near Term Deal Is Highly Unlikely; Is Referring to Evening Standard Report That Suggested GSK, Gilead, or Novartis Would Be Looking At A Possible Acquisition Of United Therapeutics",2017-08-04 14:13:00-04:00,UTHR,positive
1302119.0,20 Biggest Mid-Day Gainers For Friday,2017-08-04 12:41:00-04:00,UTHR,neutral
1302120.0,"United Therapeutics Shares Up 7.7% On M&A Chatter; GSK, Gilead, Novartis Said To Be Possibly Considering Deal For Co.",2017-08-04 09:40:00-04:00,UTHR,positive
1302121.0,28 Stocks Moving In Friday's Pre-Market Session,2017-08-04 08:30:00-04:00,UTHR,neutral
1302122.0,"UK Evening Standard Reports GSK, Gilead, Novartis Could Pay Up to $200/Share for United Therapeutics",2017-08-04 08:00:00-04:00,UTHR,positive
1302123.0,UPDATE: United Therapeutics Says Expects To Vigorously Enforce IP Rights Related To Tyvaso,2017-07-28 06:20:00-04:00,UTHR,positive
1302124.0,8-K From United Therapeutics Shows Co. Filed With District Court Deal With Watson To Stay Case Until PTAB Resolves Watson' Petitions For IPR,2017-07-28 06:19:00-04:00,UTHR,positive
1302125.0,"United Therapeutics Reports Q2 Adj. EPS $4.37 vs $3.61 Est., Sales $444.6M vs $391.5M Est.",2017-07-27 06:09:00-04:00,UTHR,positive
1302126.0,"Earnings Scheduled For July 27, 2017",2017-07-27 05:07:00-04:00,UTHR,neutral
1302127.0,Oppenheimer Analysts Release 28 Best Ideas List,2017-06-29 13:24:00-04:00,UTHR,positive
1302128.0,"Companies Holding Shareholder Meetings Today Include: AC Immune, AIG, Signet Jewelers, Trans World Entertainment, And United Therapeutics",2017-06-28 08:46:00-04:00,UTHR,positive
1302129.0,"Kansas City Southern, Snap, United Therapeutics: Fast Money Picks For June 9",2017-06-09 06:46:00-04:00,UTHR,positive
1302130.0,"3D Systems, United Therapeutics Announce Bioprinting Agreement",2017-04-26 06:23:00-04:00,UTHR,positive
1302131.0,"United Therapeutics Q1 EPS $3.61 vs $3.54 Est, Sales $370.5M vs $398.2M Est",2017-04-26 06:14:00-04:00,UTHR,positive
1302132.0,"Respira Therapeutics Enters Into Strategic Partnership With United Therapeutics For Development, Exclusive License Of Respira's RT234",2017-04-12 09:47:00-04:00,UTHR,positive
1302133.0,Your Cheat Sheet For Q1 Biotech Earnings,2017-04-06 12:47:00-04:00,UTHR,negative
1302134.0,12 Biggest Mid-Day Losers For Monday,2017-04-03 13:06:00-04:00,UTHR,negative
1302135.0,United Therapeutics Falls After US Launch Of RemoSynch Gets Delayed,2017-04-03 11:09:00-04:00,UTHR,positive
1302136.0,UPDATE: Oppenheimer Says 'We Stay Bullish' on United Therapeutics,2017-04-03 11:02:00-04:00,UTHR,positive
1302137.0,Hearing Oppenheimer Commenting on United Therapeutics: 'RemoSynch Pump Delays Jars Sentiment; Numbers Don't Change',2017-04-03 11:01:00-04:00,UTHR,positive
1302138.0,22 Stocks Moving In Monday's Pre-Market Session,2017-04-03 08:35:00-04:00,UTHR,neutral
1302139.0,United Therapeutics Says the US Launch of RemoSynch will be Delayed due to Regulatory Delays,2017-04-03 06:04:00-04:00,UTHR,positive
1302140.0,SteadyMed Reports Received Favorable Ruling in IPR Against United Therapeutics Patent,2017-03-31 14:20:00-04:00,UTHR,positive
1302141.0,"UPDATE: United Therapeutics is Evaluating Options, Including 'possibility of immediately exercising its right of appeal to the U.S. Court of Appeals for the Federal Circuit or first requesting a rehearing before the PTAB'",2017-03-31 13:18:00-04:00,UTHR,positive
1302142.0,UPDATE: United Therapeutics Says PTAB Found All Claims of '393 Patent Are Not Patentable,2017-03-31 13:17:00-04:00,UTHR,positive
1302143.0,"United Therapeutics Reports Decision from Patent Trial, Appeal Board, Issuance of New Patents",2017-03-31 13:17:00-04:00,UTHR,positive
1302144.0,United Therapeutics Sells off to Low of $133.07 on Volume,2017-03-31 13:16:00-04:00,UTHR,positive
1302145.0,"Benzinga's Top Upgrades, Downgrades For March 30, 2017",2017-03-30 09:42:00-04:00,UTHR,positive
1302146.0,"UBS Initiates Coverage On United Therapeutics With Sell, Announces $112 Price Target",2017-03-30 07:11:00-04:00,UTHR,positive
1302147.0,18 Biggest Mid-Day Losers For Thursday,2017-03-16 13:10:00-04:00,UTHR,negative
1302148.0,"Benzinga's Top Upgrades, Downgrades For March 16, 2017",2017-03-16 09:30:00-04:00,UTHR,positive
1302149.0,Credit Suisse Initiates Coverage On United Therapeutics With Underperform,2017-03-16 09:20:00-04:00,UTHR,positive
1302150.0,"Northwell Health, United Therapeutics Announce Strategic Partnership to Advance Bioelectronic Medicine and Cell Therapy",2017-03-09 06:05:00-05:00,UTHR,positive
1302151.0,"Jefferies Downgrades United Therapeutics To Underperform, Maintains $116 Price Target",2017-03-06 08:40:00-05:00,UTHR,positive
1302152.0,"United Therapeutics Q4 EPS $4.12 vs $3.61 Est, Revenue $409.0M vs $415.5M Est, May Not Compare",2017-02-22 06:02:00-05:00,UTHR,positive
1302153.0,"Earnings Scheduled For February 22, 2017",2017-02-22 04:35:00-05:00,UTHR,neutral
1302154.0,Your Guide To 2017's Emerging Pharmaceuticals Catalysts,2017-02-07 14:39:00-05:00,UTHR,neutral
1302155.0,Standpoint Research Downgrades United Therapeutics to Hold,2017-01-19 12:33:00-05:00,UTHR,positive
1302156.0,13 Emerging Biotechs With Catalysts In 2017,2017-01-03 14:22:00-05:00,UTHR,neutral
1302157.0,United Therapeutics Spikes to High on Volume,2016-12-30 14:03:00-05:00,UTHR,positive
1302158.0,Here's Oppenheimer's List Of The 29 Best Stocks For 2017,2016-12-19 09:33:00-05:00,UTHR,positive
1302159.0,"Oppenheimer Initiates Coverage On United Therapeutics at Outperform, Announces $160.00 Target",2016-12-14 16:59:00-05:00,UTHR,positive
1302160.0,"Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion",2016-11-29 10:39:00-05:00,UTHR,neutral
1302161.0,7 Biggest Price Target Changes For Tuesday,2016-11-29 09:39:00-05:00,UTHR,neutral
1302162.0,Barclays Downgrades United Therapeutics to Underweight,2016-11-29 05:57:00-05:00,UTHR,positive
1302163.0,"10 Stocks That Rallied Four Days, Then Sold Off Yesterday",2016-11-02 07:36:00-04:00,UTHR,neutral
1302164.0,7 Biggest Price Target Changes For Friday,2016-10-28 09:37:00-04:00,UTHR,neutral
1302165.0,Benzinga's Top Upgrades,2016-10-28 08:59:00-04:00,UTHR,positive
1302166.0,5 Stocks That Rallied Three Days On Increasing Volume,2016-10-28 07:07:00-04:00,UTHR,neutral
1302167.0,"Ladenburg Thalmann Upgrades United Therapeutics Corporation - Common Stock to Buy, Raises to $138.00",2016-10-28 07:03:00-04:00,UTHR,positive
1302168.0,20 Stocks That Rallied Three Days On No News,2016-10-28 05:58:00-04:00,UTHR,negative
1302169.0,"United Therapeutics Q3 EPS $4.36 vs $3.34 Est, Revenue $408.2M vs $402.4M Est",2016-10-27 06:10:00-04:00,UTHR,positive
1302170.0,6 Stocks Which Plummeted Three Days On Increasing Volume,2016-10-21 06:51:00-04:00,UTHR,neutral
1302171.0,10 LGBT CEOs Who Weren't Afraid To Come Out,2016-10-11 13:50:00-04:00,UTHR,neutral
1302172.0,5 Stocks Which Plummeted Three Days On Increasing Volume,2016-09-08 14:45:00-04:00,UTHR,neutral
1302173.0,United Therapeutics Hurt By Competitive Pressure,2016-08-22 12:13:00-04:00,UTHR,negative
1302174.0,"United Therapeutics Reports Q2 Adj. EPS $4.55 vs $2.56 in Same Qtr. Last Year, Sales $412.6M vs $395M Est.",2016-07-28 07:27:00-04:00,UTHR,positive
1302175.0,H.C. Wainwright Downgrades United Therapeutics To Neutral,2016-06-15 12:04:00-04:00,UTHR,positive
1302176.0,7 Largest Price Target Changes For Wednesday,2016-06-15 09:29:00-04:00,UTHR,neutral
1302177.0,Benzinga's Top Downgrades,2016-06-15 09:03:00-04:00,UTHR,positive
1302178.0,"H.C. Wainwright Downgrades United Therapeutics to Neutral, Lowers PT to $95.00",2016-06-15 07:03:00-04:00,UTHR,positive
1302179.0,Benzinga's Top Downgrades,2016-05-24 09:24:00-04:00,UTHR,positive
1302180.0,"Argus Downgrades United Therapeutics To Hold, Cites 'Challenging Outlook'",2016-05-24 08:08:00-04:00,UTHR,positive
1302181.0,Argus Research Downgrades United Therapeutics to Hold,2016-05-24 07:16:00-04:00,UTHR,positive
1302182.0,Ladenburg Thalmann Downgrades United Therapeutics to Neutral,2016-04-29 07:23:00-04:00,UTHR,positive
1302183.0,Stocks Hitting 52-Week Lows,2016-04-28 10:12:00-04:00,UTHR,negative
1302184.0,"United Therapeutics Reports Q1 Adj. EPS $3.02 vs $3.21 Est., Sales $369M vs $397.4M Est.",2016-04-28 06:13:00-04:00,UTHR,positive
1302185.0,"United Therapeutics Announces Roger Jeffs, Ph.D. has Stepped Down as President and Co-CEO, Michael Benkowitz Named President, COO",2016-04-28 06:11:00-04:00,UTHR,positive
1302186.0,SteadyMed Announces USPTO Initiating Inter Partes Review Against United Therapeutics,2016-04-11 07:05:00-04:00,UTHR,positive
1302187.0,United Therapeutics Says Informed by Medtronics that FDA issued Response Letter Indicating PMA is Not Approvable; UTHR Expects FDA Action in 2016 Regarding NDA Seeking FDA Approval of New Labeling for Remodulin,2016-03-24 06:19:00-04:00,UTHR,positive
1302188.0,"Barclays Maintains Equal-weight on United Therapeutics, Lowers PT to $145.00",2016-02-26 05:40:00-05:00,UTHR,positive
1302189.0,"United Therapeutics Reports Q4 EPS $2.10 Vs Est $2.55, Sales $405M Vs Est $388.29M",2016-02-25 06:05:00-05:00,UTHR,positive
1302190.0,"Earnings Scheduled For February 25, 2016",2016-02-25 04:02:00-05:00,UTHR,neutral
1302191.0,"Standpoint Research Upgrades United Therapeutics to Buy, Announces $148.00 PT",2016-02-10 12:53:00-05:00,UTHR,positive
1302192.0,"Teva Pharma and United Therapeutics Announce Settlement of Remodulin Patents, Teva Granted Non-Exclusive License to Manufacture Generic in US",2016-01-19 06:09:00-05:00,UTHR,positive
1302193.0,Every Biotech Catalyst Wedbush Is Watching In 2016,2016-01-02 20:20:00-05:00,UTHR,neutral
1302194.0,Mid-Morning Market Update: Markets Down; Ford Earnings Miss Views,2015-10-27 10:27:00-04:00,UTHR,negative
1302195.0,"United Therapeutics Q3 EPS $3.55 vs $2.36 est, Revenue $386M vs $363.5M est",2015-10-27 06:04:00-04:00,UTHR,positive
1302196.0,Cowen: In Biotech Earnings We Trust,2015-10-19 10:02:00-04:00,UTHR,positive
1302197.0,United Therapeutics Announces Additional $500 M Share Buybacke Program,2015-10-15 06:00:00-04:00,UTHR,positive
1302198.0,United Therapeutics Reports Settlement of Patent Litigation with Sandoz,2015-09-30 06:03:00-04:00,UTHR,positive
1302199.0,"Synthetic Genomics Inc. Increases Collaborative Research and Development Agreement with Lung Biotechnology PBC, a Subsidiary of United Therapeutics Corporation; Lung Biotech Makes Additional $50M Equity Inv. In SGI",2015-09-22 16:31:00-04:00,UTHR,positive
1302200.0,Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest Profit Margin,2015-08-31 04:51:00-04:00,UTHR,positive
1302201.0,"Wedbush Maintains Outperform on United Therapeutics, Raises PT to $244.00",2015-08-19 20:23:00-04:00,UTHR,positive
1302202.0,"Benzinga's M&A Chatter for Wednesday August 19, 2015",2015-08-19 18:27:00-04:00,UTHR,neutral
1302203.0,United Therapeutics To Sell Priority Review Voucher To AbbVie For $350M,2015-08-19 06:03:00-04:00,UTHR,positive
1302204.0,"Wedbush's Moussatos Reiterates Outperform, $209 Price Target on United Therapeutics Following Unituxin Being Granted Market Authorization by EC",2015-08-17 11:57:00-04:00,UTHR,positive
1302205.0,US Stock Futures Flat Ahead Of Housing Data,2015-08-17 07:29:00-04:00,UTHR,neutral
1302206.0,EC Grants Marketing Authorization for Unituxin for Treatment of Paediatric High-Risk Neuroblastoma,2015-08-17 06:03:00-04:00,UTHR,positive
1302207.0,"United Therapeutics Q2 EPS $2.55 vs $2.31 est, Revenue $347.2M vs $360M est",2015-07-28 06:16:00-04:00,UTHR,positive
1302208.0,New Alzheimer's Trials Could Produce The Most Important Drugs In History,2015-07-21 15:14:00-04:00,UTHR,positive
1302209.0,"United Therapeutics CEO Jeffs Acquires 10,000 Shares @$51.37/Share -Form 4",2015-06-19 03:58:00-04:00,UTHR,positive
1302210.0,United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso,2015-06-15 09:01:00-04:00,UTHR,positive
1302211.0,Who's The Next Big Pharma Acquisition?,2015-05-29 11:20:00-04:00,UTHR,neutral
1302212.0,EMA Recommends Approval of United Therapeutics Neuroblastoma Drug Unituxin,2015-05-22 07:04:00-04:00,UTHR,positive
1302213.0,Apple's Angela Ahrendts Is Nation's Best-Paid Female Executive,2015-05-05 13:40:00-04:00,UTHR,neutral
1302214.0,"Earnings Scheduled For April 28, 2015",2015-04-28 04:35:00-04:00,UTHR,neutral
1302215.0,Biotech: Anatomy Of An Investing Mania?,2015-04-07 11:39:00-04:00,UTHR,neutral
1302216.0,5 Mid-Cap Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years,2015-03-17 08:59:00-04:00,UTHR,positive
1302217.0,Argus Research Upgrades United Therapeutics to Buy,2015-03-12 07:39:00-04:00,UTHR,positive
1302218.0,FDA Approves United Therapeutics' Unituxin For Treatment Of High Risk Neuroblastoma,2015-03-10 11:14:00-04:00,UTHR,positive
1302219.0,Shares of United Therapeutics Bounce from Session Lows as Earlier Heard Report FDA Has Approved Co.'s Unituxin,2015-03-10 10:31:00-04:00,UTHR,positive
1302220.0,"United Therapeutics Q4 EPS $3.21 vs $2.05, May Not Compare,  Revenue $346.4M vs $336.2M",2015-02-24 06:05:00-05:00,UTHR,positive
1302221.0,"Earnings Scheduled For February 24, 2015",2015-02-24 04:57:00-05:00,UTHR,neutral
1302222.0,What Investors Are Looking At In The Stem Cell Sector,2015-01-13 11:48:00-05:00,UTHR,neutral
1302223.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1,2015-01-12 08:55:00-05:00,UTHR,neutral
1302224.0,Credit Suisse's 4 Healthcare Stocks To Avoid,2015-01-11 13:15:00-05:00,UTHR,positive
1302225.0,UPDATE: Barclays Initiates Coverage On United Therapeutics,2015-01-06 13:03:00-05:00,UTHR,positive
1302226.0,"Barclays Initiates Coverage on United Therapeutics at Equal-weight, Announces $135.00 PT",2015-01-06 06:22:00-05:00,UTHR,positive
1302227.0,UPDATE: BTIG Initiates Coverage On United Therapeutics,2015-01-05 19:14:00-05:00,UTHR,positive
1302228.0,BTIG Research Initiates Coverage on United Therapeutics at Neutral,2015-01-05 17:27:00-05:00,UTHR,positive
1302229.0,19 Lesser-Known Biotech Stocks With Robust Drug Pipelines,2014-12-31 08:59:00-05:00,UTHR,positive
1302230.0,US Stock Futures Edge Higher Ahead Of Economic Data,2014-12-31 06:57:00-05:00,UTHR,neutral
1302231.0,United Therapeutics Announces Agreement for New Remodulin Delivery System; Terms Not Disclosed,2014-12-31 06:01:00-05:00,UTHR,positive
1302232.0,United Therapeutics Submits Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin,2014-12-24 11:29:00-05:00,UTHR,positive
1302233.0,"United Therapeutics Names Roger Jeffs, Ph.D. President and Co-CEO",2014-12-17 06:01:00-05:00,UTHR,positive
1302234.0,Benzinga's Top Downgrades,2014-12-11 09:03:00-05:00,UTHR,positive
1302235.0,Credit Suisse Downgrades United Therapeutics To Underperform,2014-12-11 08:06:00-05:00,UTHR,positive
1302236.0,"US Stock Futures Edge Higher Ahead Of Retail Sales, Jobless Claims Data",2014-12-11 07:01:00-05:00,UTHR,neutral
1302237.0,"Credit Suisse Downgrades United Therapeutics Corporation to Underperform, Raises PT to $120.00",2014-12-11 06:08:00-05:00,UTHR,positive
1302238.0,Apple's Tim Cook And 5 Other Notable LGBT CEOs,2014-10-30 11:45:00-04:00,UTHR,neutral
1302239.0,"Worst Performing Industries For October 28, 2014",2014-10-28 11:13:00-04:00,UTHR,negative
1302240.0,United Therapeutics Corporation Reports Q3 EPS of $3.91 vs $1.97 Est; Revenue of $330.0M vs $335.08M Est,2014-10-28 06:06:00-04:00,UTHR,positive
1302241.0,"Earnings Scheduled For October 28, 2014",2014-10-28 05:25:00-04:00,UTHR,neutral
1302242.0,"Standpoint Research Upgrades United Therapeutics Corporation to Buy, Announces $144.00 PT",2014-10-15 13:19:00-04:00,UTHR,positive
1302243.0,Standpoint Research Downgrades United Therapeutics Corporation to Hold,2014-09-22 11:17:00-04:00,UTHR,positive
1302244.0,Stocks Hitting 52-Week Highs,2014-09-17 10:01:00-04:00,UTHR,neutral
1302245.0,Axsome Therapeutics Announces Appointments to Its Board of Directors,2014-09-17 07:32:00-04:00,UTHR,neutral
1302246.0,Pluristem Evaluating Strategic Opportunities in Japan ,2014-09-16 05:22:00-04:00,UTHR,positive
1302247.0,United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of PAH,2014-09-08 05:16:00-04:00,UTHR,positive
1302248.0,Cowen Raises PT on United Therapeutics from $130 to $140 with Outperform Rating,2014-08-29 14:58:00-04:00,UTHR,positive
1302249.0,Wedbush Lifts Target on United Therapeutics Corporation from $133 to $141,2014-08-29 13:16:00-04:00,UTHR,positive
1302250.0,"UPDATE: United Therapeutics Release Shows Judge Found Patent Expiring '17 'Both Valid and Enforceable Against Sandoz,' Found '29 Patent 'Vaild But Would Not Be Infringed by Sandoz'",2014-08-29 12:56:00-04:00,UTHR,positive
1302251.0,United Therapeutics Announces NJ District Court Rule In Favor of Co. in Remodulin Patent Case,2014-08-29 12:52:00-04:00,UTHR,positive
1302252.0,"United Therapeutics Gets Favorable Ruling, Shares Flying Higher",2014-08-29 12:38:00-04:00,UTHR,positive
1302253.0,"ISI Analyst Suggesting United Therapeutics Ruling Places a Large Overhang Behind the Co., Recommends Investors Consider Owning Shares on Potential for Strong Oral Orenitram Sales",2014-08-29 11:43:00-04:00,UTHR,positive
1302254.0,Hearing Positive Court Ruling for United Therapeutics,2014-08-29 10:23:00-04:00,UTHR,positive
1302255.0,United Therapeutics Spikes Higher,2014-08-29 10:19:00-04:00,UTHR,positive
1302256.0,United Therapeutics Reports Q2 Adjusted EPS of $2.30 vs $1.75 Est; Revenue of $322.80M vs $308.04M Est,2014-07-29 06:16:00-04:00,UTHR,positive
1302257.0,"Earnings Scheduled For July 29, 2014",2014-07-29 05:16:00-04:00,UTHR,neutral
1302258.0,United Therapeutics Board Approves Additional $500M Share-Buyback Program,2014-06-27 06:01:00-04:00,UTHR,positive
1302259.0,Credit Suisse Upgrades United Therapeutics Corporation to Outperform,2014-06-16 08:04:00-04:00,UTHR,positive
1302260.0,Supernus Revives $2M Milestone for United Therapeutics Orenitram Launch,2014-05-20 17:04:00-04:00,UTHR,positive
1302261.0,Synthetic Genomics Signs Collaborative Agreement with United Therapeutics Subsidiary Lung Biotechnology ,2014-05-06 06:18:00-04:00,UTHR,positive
1302262.0,United Therapeutics Reports Q1 Adjusted EPS of $1.77 vs $1.65 Est; Revenue of $289.40M vs $300.14M Est,2014-04-29 06:06:00-04:00,UTHR,positive
1302263.0,"Earnings Scheduled For April 29, 2014",2014-04-29 05:16:00-04:00,UTHR,neutral
1302264.0,Standpoint Research Upgrades United Therapeutics Corporation to Buy,2014-04-07 11:20:00-04:00,UTHR,positive
1302265.0,"Japan's Ministry of Health, Labour and Welfare Grants Approval for United Therapeutics' Remodulin ",2014-03-26 06:09:00-04:00,UTHR,positive
1302266.0,Hearing Deutsche Bank Negative on United Therapeutics ,2014-03-11 12:20:00-04:00,UTHR,negative
1302267.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio ,2014-02-28 04:30:00-05:00,UTHR,negative
1302268.0,United Therapeutics Reports Q4 Adjusted EPS of $3.19 vs $1.51 Est; Revenue of $289.0M vs $295.43M Est,2014-02-25 06:22:00-05:00,UTHR,positive
1302269.0,"Earnings Scheduled For February 25, 2014",2014-02-25 04:28:00-05:00,UTHR,neutral
1302270.0,The Five Best Performing Stocks From Monday,2013-12-24 08:11:00-05:00,UTHR,positive
1302271.0,Supernus Confirms FDA Approval of United Therapeutics' Orenitram,2013-12-23 17:10:00-05:00,UTHR,positive
1302272.0,Ladenburg Thalmann Upgrades United Therapeutics Corporation to Buy,2013-12-23 14:07:00-05:00,UTHR,positive
1302273.0,"United Therapeutic Shares Rocketing Higher Following FDA Approval of Orenitram, JP Morgan Upgrade ",2013-12-23 11:11:00-05:00,UTHR,positive
1302274.0,Benzinga's Volume Movers,2013-12-23 10:41:00-05:00,UTHR,neutral
1302275.0,Stocks Hitting 52-Week Highs,2013-12-23 10:31:00-05:00,UTHR,neutral
1302276.0,Mid-Morning Market Update: Markets Surge; Seagate To Acquire Xyratex For $374M,2013-12-23 10:26:00-05:00,UTHR,neutral
1302277.0,Morning Market Movers ,2013-12-23 09:55:00-05:00,UTHR,neutral
1302278.0,UPDATE: United Therapeutics Announces FDA Approval of OrenitramExtended-Release Tablets forTreatment of Pulmonary Arterial Hypertension,2013-12-23 08:58:00-05:00,UTHR,positive
1302279.0,Benzinga's Top Upgrades,2013-12-23 08:48:00-05:00,UTHR,positive
1302280.0,"JP Morgan Upgrades United Therapeutics Corporation to Neutral, Raises PT to $90.00",2013-12-23 08:45:00-05:00,UTHR,positive
1302281.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2013-12-10 04:08:00-05:00,UTHR,negative
1302282.0,US Stock Futures Mixed; Japan Posts Current Account Deficit,2013-12-09 07:12:00-05:00,UTHR,negative
1302283.0,United Therapeutics Receives Subpoena from Office of Inspector General ,2013-12-09 06:10:00-05:00,UTHR,positive
1302284.0,Stocks Hitting 52-Week Highs,2013-11-07 10:11:00-05:00,UTHR,neutral
1302285.0,Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates,2013-11-07 04:19:00-05:00,UTHR,positive
1302286.0,US Stock Futures Flat Ahead Of Fed,2013-10-29 07:12:00-04:00,UTHR,neutral
1302287.0,UPDATE: United Therapeutics Posts Weaker-Than-Expected Q3 Earnings,2013-10-29 07:04:00-04:00,UTHR,positive
1302288.0,United Therapeutics Reports Q3 EPS of $2.98 Which May Not Compare $1.59 Est; Revenue of $302.20M Which May Not Compare $279.02M Est,2013-10-29 06:15:00-04:00,UTHR,positive
1302289.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin,2013-10-07 04:38:00-04:00,UTHR,positive
1302290.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Profit Margin,2013-09-26 05:13:00-04:00,UTHR,positive
1302291.0,United Therapeutics Reports FDA Acceptance of Second Submission of Oral Treprostinil NDA,2013-09-11 17:01:00-04:00,UTHR,positive
1302292.0,Standpoint Research Downgrades United Therapeutics Corporation to Hold,2013-07-30 12:02:00-04:00,UTHR,positive
1302293.0,"BMO Capital Maintains Market Perform on United Therapeutics Corporation, Raises PT to $68.00",2013-07-26 09:09:00-04:00,UTHR,positive
1302294.0,United Therapeutics Corporation Reports Q2 EPS of $3.11 vs $1.47 Est; Revenue of $280.60M vs $250.17M Est,2013-07-25 06:39:00-04:00,UTHR,positive
1302295.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin,2013-07-15 05:09:00-04:00,UTHR,positive
1302296.0,Standpoint Upgrades United Therapeutics from Hold to Buy,2013-06-20 14:20:00-04:00,UTHR,positive
1302297.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROA,2013-06-17 04:08:00-04:00,UTHR,positive
1302298.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2013-05-24 04:04:00-04:00,UTHR,negative
1302299.0,United Therapeutics Shares Sink as Standpoint Downgrades to Hold,2013-05-15 12:55:00-04:00,UTHR,positive
1302300.0,United Therapeutics Corporation Reports Q1 Ex-Charges EPS of $2.46 vs $1.47 Est; Revenue of $245.10M vs $241.14M Est,2013-04-25 06:16:00-04:00,UTHR,positive
1302301.0,13 Drugs Pending FDA Approval in 2013,2013-03-26 13:19:00-04:00,UTHR,positive
1302302.0,"Mid-Morning Market Update: Markets Rise On Cyprus Deal, Dollar General Posts Higher Profit",2013-03-25 11:03:00-04:00,UTHR,positive
1302303.0,Benzinga's Top Pre-Market Losers,2013-03-25 08:39:00-04:00,UTHR,negative
1302304.0,United Therapeutics Receives Second CRL from FDA for Oral Treprostinil NDA ,2013-03-25 05:49:00-04:00,UTHR,positive
1302305.0,Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS,2013-03-12 04:40:00-04:00,UTHR,positive
1302306.0,"UPDATE: Deutsche Bank Reiterates Hold Rating, Raises PT on United Therapeutics Corporation on Cut Expense Numbers",2013-02-27 10:44:00-05:00,UTHR,positive
1302307.0,"Deutsche Bank Maintains Hold on United Therapeutics Corporation, Raises PT to $56.00",2013-02-27 07:46:00-05:00,UTHR,positive
1302308.0,Brean Capital Downgrades United Therapeutics Corporation to Hold,2013-02-26 13:07:00-05:00,UTHR,positive
1302309.0,United Therapeutics Spikes Lower,2013-02-26 13:03:00-05:00,UTHR,positive
1302310.0,United Therapeutics Corporation Reports Q4 EPS of $2.50 vs $1.25 Est,2013-02-26 06:18:00-05:00,UTHR,positive
1302311.0,"Earnings Scheduled For February 26, 2013",2013-02-26 04:24:00-05:00,UTHR,neutral
1302312.0,Standpoint Research Upgrades United Therapeutics Corporation to Buy,2013-02-04 10:20:00-05:00,UTHR,positive
1302313.0,A Peek Into The Market Before The Trading Starts,2013-02-04 07:10:00-05:00,UTHR,neutral
1302314.0,United Therapeutics Authorizes Additional $420M Share Buyback,2013-02-04 06:03:00-05:00,UTHR,positive
1302315.0,Guggenheim Securities Initiates Coverage on United Therapeutics Corporation at Neutral,2013-01-23 08:20:00-05:00,UTHR,positive
1302316.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Cash,2013-01-08 04:07:00-05:00,UTHR,positive
1302317.0,UPDATE: Goldman Sachs Downgrades United Therapeutics Corporation to Sell; Upside Capped  ,2012-12-13 08:48:00-05:00,UTHR,positive
1302318.0,Benzinga's Top Downgrades,2012-12-13 07:26:00-05:00,UTHR,positive
1302319.0,"Goldman Sachs Downgrades United Therapeutics Corporation to Sell, Maintains $50.00 PT",2012-12-13 06:18:00-05:00,UTHR,positive
1302320.0,United Therapeutics Reports Q3 EPS $1.46 vs $1.26 Est; Revenues $242.5M vs $227.63M Est,2012-11-01 08:44:00-04:00,UTHR,positive
1302321.0,Benzinga Mid-Morning Market Update,2012-10-24 10:41:00-04:00,UTHR,neutral
1302322.0,"BMO Capital Markets Downgrades United Therapeutics from Outperform to Market Perform, Lowers PT from $63 to $50",2012-10-24 07:56:00-04:00,UTHR,positive
1302323.0,UPDATE: JP Morgan Downgrades United Therapeutics to Underweight,2012-10-24 07:21:00-04:00,UTHR,positive
1302324.0,"JP Morgan Downgrades United Therapeutics from Neutral to Underweight, Lowers PT from $50 to $40",2012-10-24 05:54:00-04:00,UTHR,positive
1302325.0,United Therapeutics Announces Receipt Of Complete Response Letter For Oral Treprostinil NDA,2012-10-23 16:23:00-04:00,UTHR,positive
1302326.0,"Deutsche Bank Maintains United Therapeutics at Hold, Raises PT from $53 to $58",2012-07-26 15:13:00-04:00,UTHR,positive
1302327.0,"Deutsche Bank Maintains United Therapeutics at Hold, Raises PT from $53 to $58",2012-07-26 15:11:00-04:00,UTHR,positive
1302328.0,United Therapeutics Reports Q2 EPS $2.37 May Not Compare vs $1.12 Est; Revenues $225.6M vs $213.33M Est,2012-07-26 06:44:00-04:00,UTHR,positive
1302329.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2012-07-24 04:38:00-04:00,UTHR,negative
1302330.0,"Financial Breakfast: Morning News Summary for June 27, 2012",2012-06-27 07:25:00-04:00,UTHR,neutral
1302331.0,A Peek Into The Market Before The Trading Starts,2012-06-27 07:22:00-04:00,UTHR,neutral
1302332.0,United Therapeutics Announces Additional $100 Million Share Repurchase Program ,2012-06-27 06:34:00-04:00,UTHR,positive
1302333.0,"Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying",2012-06-26 10:13:00-04:00,UTHR,neutral
1302334.0,United Therapeutics: Meeting Unmet Clinical Needs,2012-06-22 21:35:00-04:00,UTHR,positive
1302335.0,UPDATE: Ladenburg Thalmann Lowers United Therapeutics' PT,2012-04-30 09:58:00-04:00,UTHR,positive
1302336.0,"Ladenburg Thalmann Maintains United Therapeutics at Buy, Lowers PT from $61 to $58",2012-04-30 07:50:00-04:00,UTHR,positive
1302337.0,UPDATE: Canaccord Downgrades United Therapeutics; Lowers PT,2012-04-27 10:00:00-04:00,UTHR,positive
1302338.0,"Canaccord Downgrades United Therapeutics from Buy to Hold, Lowers PT from $56 to $44",2012-04-27 07:56:00-04:00,UTHR,positive
1302339.0,United Therapeutics Reports Q1 EPS $2.08 May Not Compare vs $0.93 Est; Revenues $204.2M vs $203.78M Est,2012-04-26 06:56:00-04:00,UTHR,positive
1302340.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROE,2012-04-24 03:44:00-04:00,UTHR,positive
1302341.0,Benzinga's Top Downgrades,2012-04-12 08:23:00-04:00,UTHR,positive
1302342.0,"Canaccord Initiates Coverage on United Therapeutics at Buy, Announces PT of $56",2012-03-26 08:56:00-04:00,UTHR,positive
1302343.0,A Peek Into The Market Before The Trading Starts,2012-03-15 07:31:00-04:00,UTHR,neutral
1302344.0,United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents ,2012-03-15 07:02:00-04:00,UTHR,negative
1302345.0,Oral Treprostinil New Drug Application Accepted by FDA for Review ,2012-02-21 07:06:00-05:00,UTHR,positive
1302346.0,"Brean Murray Carret & Co. Maintains United Therapeutics at Buy, Raises PT from $55 to $57",2012-02-14 11:39:00-05:00,UTHR,positive
1302347.0,Deutsche Bank: United Therapeutics' Light Revenue Likely Due to Seasonality,2012-02-14 09:00:00-05:00,UTHR,positive
1302348.0,"Collins Stewart: United Therapeutics Reiterates FY12/FY13 Revenue Guidance, Despite 4Q11 Miss",2012-02-14 08:57:00-05:00,UTHR,positive
1302349.0,United Therapeutics Reports Q4 EPS $0.79 vs $0.87 Est; Revenues $195.20M vs $204.81M Est			 ,2012-02-14 07:05:00-05:00,UTHR,positive
1302350.0,United Therapeutics Receives Paragraph IV Notice Letter for Remodulin  ,2012-02-06 07:02:00-05:00,UTHR,positive
1302351.0,United Therapeutics Spiking Lower on FDA Notice Regarding Generic Remodulin,2012-01-24 14:35:00-05:00,UTHR,positive
1302352.0,United Therapeutics Spiking Lower on Heavy Volume,2012-01-24 14:34:00-05:00,UTHR,positive
1302353.0,United Therapeutics Spiking Lower on Heavy Volume,2012-01-13 15:03:00-05:00,UTHR,positive
1302354.0,Eight Healthcare Stocks Insiders Are Bullish About,2011-12-27 15:04:00-05:00,UTHR,neutral
1302355.0,Wedbush Maintains Outperform on United Therapeutics Ahead of FDA Vote,2011-12-27 11:30:00-05:00,UTHR,positive
1302356.0,JP Morgan Neutral on United Therapeutics After IV Remodulin Approval ,2011-12-27 09:05:00-05:00,UTHR,positive
1302357.0,Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union ,2011-12-27 07:01:00-05:00,UTHR,positive
1302358.0,Pluristem Therapeutics' CEO Letter to Shareholders  ,2011-11-22 08:09:00-05:00,UTHR,neutral
1302359.0,"Pluristem Therapeutics' CEO Letter to Shareholders: ""Current Data Suggest that Approx 20% of CLI patients will Die Within the first 6-12 Months""",2011-11-22 08:03:00-05:00,UTHR,negative
1302360.0,United Therapeutics Reports Q3 EPS $1.65 May Not Compare $0.73 Est; Revenues $201.7M vs $194.77M Est		,2011-10-27 07:05:00-04:00,UTHR,positive
1302361.0,United Therapeutics Prices Private Offering of Convertible Senior Notes and Announces Concurrent Exercise of Overallotment Option  ,2011-10-12 07:02:00-04:00,UTHR,positive
1302362.0,ISI Group Comments On United Therapeutics' $212M Share Re-Purchase Announcement,2011-10-11 08:05:00-04:00,UTHR,positive
1302363.0,United Therapeutics Announces Proposed Private Offering of $210M of Convertible Senior Notes; Authorizes of Stock Repurchase Program  ,2011-10-11 07:16:00-04:00,UTHR,positive
1302364.0,United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program,2011-10-10 07:00:00-04:00,UTHR,positive
1302365.0,Notable Call Options Activity in United Therapeutics,2011-10-07 10:37:00-04:00,UTHR,positive
1302366.0,ISI Group Defending United Therapeutics ,2011-09-26 12:33:00-04:00,UTHR,positive
1302367.0,Pluristem Therapeutics CEO Letter to Shareholders ,2011-09-16 06:55:00-04:00,UTHR,neutral
1302368.0,UPDATE: Goldman Sachs Upgrades Onyx Pharmaceuticals to Buy,2011-09-15 07:24:00-04:00,UTHR,neutral
1302369.0,UPDATE: Goldman Sachs Downgrades United Therapeutics to Neutral,2011-09-15 07:20:00-04:00,UTHR,positive
1302370.0,"Goldman Sachs Downgrades United Therapeutics, Removes From CL-Buy List",2011-09-15 05:59:00-04:00,UTHR,positive
1302371.0,UPDATE: Ladenburg Thalmann Lowers PT on United Therapeutics,2011-08-25 09:27:00-04:00,UTHR,positive
1302372.0,Ladenburg Thalmann Lowers PT On United Therapeutics To $61,2011-08-25 08:38:00-04:00,UTHR,positive
1302373.0,UPDATE: Auriga Downgrades United Therapeutics to Hold,2011-08-25 08:20:00-04:00,UTHR,positive
1302374.0,UPDATE: Goldman Sachs Lowers PT on United Therapeutics to $52,2011-08-25 08:01:00-04:00,UTHR,positive
1302375.0,"Financial Breakfast for August 25, 2011",2011-08-25 07:47:00-04:00,UTHR,neutral
1302376.0,Benzinga's Top Downgrades,2011-08-25 07:40:00-04:00,UTHR,positive
1302377.0,"Auriga Downgrades United Therapeutics To Hold, $45 PT",2011-08-25 07:12:00-04:00,UTHR,positive
1302378.0,Goldman Sachs Lowers PT On United Therapeutics To $52 ,2011-08-25 07:02:00-04:00,UTHR,positive
1302379.0,Morning Market Losers,2011-08-24 09:51:00-04:00,UTHR,negative
1302380.0,UPDATE: Wunderlich Initiates Coverage on Edwards Lifesciences,2011-08-24 09:45:00-04:00,UTHR,neutral
1302381.0,UPDATE: J.P. Morgan Downgrades United Therapeutics to Neutral,2011-08-24 09:28:00-04:00,UTHR,positive
1302382.0,Pre-Market Losers; United Therapeutics Down 21%,2011-08-24 08:53:00-04:00,UTHR,negative
1302383.0,Deutsche Bank Downgrades United Therapeutics To Hold,2011-08-24 08:47:00-04:00,UTHR,positive
1302384.0,"JP Morgan Downgrades UTHR To Neutral, Lowers PT To $55",2011-08-24 08:24:00-04:00,UTHR,positive
1302385.0,Benzinga's Top Downgrades,2011-08-24 07:49:00-04:00,UTHR,positive
1302386.0,"Financial Breakfast for August 24, 2011",2011-08-24 07:42:00-04:00,UTHR,neutral
1302387.0,"Deutsche Bank Downgrades United Therapeutics To Hold, $53 PT",2011-08-24 07:09:00-04:00,UTHR,positive
1302388.0,FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint,2011-08-24 06:40:00-04:00,UTHR,neutral
1302389.0,Oppenheimer Comments on Product Development at United Therapeutics,2011-08-22 06:45:00-04:00,UTHR,positive
1302391.0,Biggest Gainers of the Day,2011-07-28 12:01:00-04:00,UTHR,neutral
1302392.0,United Therapeutics Reports Q2 EPS Prelim $1.27 vs $0.53 Est; Revenues $183.8M vs $180.84M Est,2011-07-28 07:17:00-04:00,UTHR,positive
1302393.0,Earnings Ahead  07-08-2011,2011-07-08 17:26:00-04:00,UTHR,neutral
1302394.0,Calls Purchased on United Therapeutics,2011-07-08 13:24:00-04:00,UTHR,positive
1302395.0,Oppenheimer Maintains Outperform on United Therapeutics,2011-06-22 08:11:00-04:00,UTHR,positive
1302396.0,Pluristem Therapeutics Pops on Licensing Pact ,2011-06-20 16:47:00-04:00,UTHR,neutral
1302397.0,Auriga Comments On United Therapeutics Top-Line Results,2011-06-07 08:50:00-04:00,UTHR,positive
1302398.0,Benzinga's Top Downgrades,2011-06-07 08:14:00-04:00,UTHR,positive
1302399.0,Jefferies Maintains Hold Rating on United Therapeutics,2011-06-07 07:30:00-04:00,UTHR,positive
1302400.0,UPDATE: Citadel Securities Color on United Therapeutics Downgrade,2011-06-07 07:30:00-04:00,UTHR,positive
1302401.0,"Citadel Downgrades United Therapeutics To Neutral, Lowers PT To $60",2011-06-07 06:09:00-04:00,UTHR,positive
1302402.0,It's Inverted Hammertime!  06-06-2011,2011-06-06 15:25:00-04:00,UTHR,neutral
1302403.0,Benzinga's Top Pre-Market NASDAQ Losers,2011-06-06 08:22:00-04:00,UTHR,negative
1302404.0,Goldman Sachs Suggests Buying Calls on United Therapeutics,2011-06-03 09:10:00-04:00,UTHR,positive
1302405.0,Goldman Sachs Reiterates Neutral on United Therapeutics Corporation,2011-06-03 07:58:00-04:00,UTHR,positive
1302406.0,Jefferies & Company Reports on United Therapeutics,2011-06-01 08:29:00-04:00,UTHR,positive
1302407.0,Benzinga's Top Upgrades,2011-05-20 08:15:00-04:00,UTHR,positive
1302408.0,UPDATE: Citadel Upgrades United Therapeutics to Add (UTHR),2011-05-20 07:25:00-04:00,UTHR,positive
1302409.0,"Citadel Upgrades UTHR To Add, Raises PT To $70",2011-05-20 06:18:00-04:00,UTHR,neutral
1302410.0,Collins Stewart Reports on United Therapeutics,2011-05-18 07:45:00-04:00,UTHR,positive
1302411.0,Goldman Sachs Suggests Buying Calls on United Therapeutics (UTHR),2011-05-11 09:25:00-04:00,UTHR,positive
1302412.0,United Therapeutics Files $50M Stock Securities Shelf -Bloomberg (UTHR),2011-05-02 16:41:00-04:00,UTHR,positive
1302413.0,Auriga Assumes Coverage Of UTHR,2011-04-29 07:49:00-04:00,UTHR,neutral
1302414.0,United Therapeutics Reports EPS of $1.29 vs. $0.64 Estimate; Revenues $165.5M vs. $178.02M Estimate (UTHR),2011-04-28 07:37:00-04:00,UTHR,positive
1302415.0,United Therapeutics (NASDAQ: UTHR) Reports EPS of $1.29 vs. $0.64 Estimate; Revenues $165.6M vs. $178.02M Estimate,2011-04-28 07:20:00-04:00,UTHR,positive
1302416.0,Puts Purchased on United Therapeutics Corporation (UTHR),2011-04-26 13:08:00-04:00,UTHR,positive
1302417.0,Oppenheimer Maintains Overweight on United Therapeutics (UTHR),2011-04-15 07:46:00-04:00,UTHR,positive
1302418.0,Auriga Comments On United Therapeutics Oral Remodulin,2011-04-14 08:44:00-04:00,UTHR,positive
1302419.0,Options Brief: United Therapeutics Corporation (UTHR),2011-04-01 11:47:00-04:00,UTHR,positive
1302420.0,United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial ,2011-03-21 07:26:00-04:00,UTHR,positive
1302421.0,JP Morgan Raises PT On United Therapeutics To $85,2011-03-18 07:16:00-04:00,UTHR,positive
1302422.0,Goldman Sachs Suggests Buying Calendar Spreads on United Therapeutics Corporation (UTHR),2011-03-09 09:51:00-05:00,UTHR,positive
1302423.0,"Goldman Sachs Comments On Healthcare Sector (HOLX, UTHR)",2011-03-03 07:25:00-05:00,UTHR,neutral
1302424.0,"Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Cash (WCRX, VRTX, ENDP, UTHR)",2011-02-24 02:44:00-05:00,UTHR,positive
1302425.0,"Goldman Sachs Initiates Neutral Rating on Smid-Cap Biotech (UTHR, VRTX, AMLN)",2011-02-08 09:20:00-05:00,UTHR,neutral
1302426.0,"Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin (ENDP, UTHR, WCRX, ALXN)",2011-01-24 01:27:00-05:00,UTHR,positive
1302427.0,Gilead Ends Letairis Trial for IPF - Analyst Blog,2010-12-23 17:03:00-05:00,UTHR,neutral
1302428.0,Gilead Ends Letairis Trial for IPF - Analyst Blog,2010-12-23 16:18:00-05:00,UTHR,neutral
1302429.0,Pfizer Drug Withdrawn from Market - Analyst Blog,2010-12-14 08:03:00-05:00,UTHR,neutral
1302430.0,Pfizer Drug Withdrawn from Market - Analyst Blog,2010-12-14 07:20:00-05:00,UTHR,neutral
1302431.0,J.P. Morgan Raising Price Target On United Therapeutics  (UTHR),2010-11-18 07:02:00-05:00,UTHR,positive
1302432.0,Higher Revs Drive UTHR - Analyst Blog,2010-11-02 11:00:00-04:00,UTHR,neutral
1302433.0,United Therapeutics (UTHR) - Zacks #1 Rank Top Performers,2010-10-28 18:33:00-04:00,UTHR,positive
1302434.0,Sales Growth Sends United Therapeutics (UTHR) Shares Up 6.8%,2010-10-28 15:14:00-04:00,UTHR,positive
1302435.0,United Therapeutics Breaking Out (UTHR),2010-10-28 11:51:00-04:00,UTHR,positive
1302436.0,"Wedbush Changes Price Targets (UTHR, ULTI, NTGR, FFIV, CSGS, CML, CALD, UA, CRDN)",2010-10-27 12:26:00-04:00,UTHR,neutral
1302437.0,Puts Purchased on United Therapeutics Corporation (UTHR),2010-10-19 11:45:00-04:00,UTHR,positive
1302438.0,Options Traders Coming After Calls in UTHR,2010-09-17 09:48:00-04:00,UTHR,neutral
1302439.0,Upside Purchased on United Therapeutics (UTHR),2010-09-10 13:10:00-04:00,UTHR,positive
1302440.0,"UTHR Up on Lower Costs, Higher Revs - Analyst Blog",2010-08-03 09:10:00-04:00,UTHR,negative
1302441.0,J.P. Morgan Upgrades United Therapeutics To Overweight (UTHR) ,2010-06-10 11:25:00-04:00,UTHR,positive
1302442.0,"Benzinga’s Top Upgrades (UTHR, MBT, CHRW, OMCL)",2010-06-10 08:06:00-04:00,UTHR,positive
1302443.0,Calls Purchased on United Therapeutics Corp. ,2010-05-20 12:58:00-04:00,UTHR,positive
1302444.0,46 Short Setups with Stop-Losses,2010-05-18 19:47:00-04:00,UTHR,neutral
1302445.0,27 Short Setups with Stop-Losses,2010-05-11 20:47:00-04:00,UTHR,neutral
1302446.0,23 Short Setups with Stop-Losses,2010-05-05 06:57:00-04:00,UTHR,neutral
1302447.0,"Top 5 Mid-Cap Stocks In The Healthcare Sector On The NASDAQ With The Lowest PEG Ratio (UTHR, WCRX, MYGN, ENDP, TLCR)",2010-05-05 06:22:00-04:00,UTHR,negative
1302448.0,"Trade Setups for April 22, 2010",2010-04-22 07:57:00-04:00,UTHR,neutral
1302449.0,16 Short Setups with Stop-Losses,2010-04-21 20:07:00-04:00,UTHR,neutral
1302450.0,"Top 5 Stocks In The Healthcare Sector With Lowest PEG (PDLI, PRX, MDCO, UTHR, CPIX)",2010-04-19 07:31:00-04:00,UTHR,negative
1302451.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,UTHR,positive
1302452.0,United Therapeutics Withdraws Application For Tyvaso Drug In EU (UTHR),2010-02-19 14:20:00-05:00,UTHR,positive
1302453.0,"UTHR Posts Strong Q4 Revenues, As Well As Expenses",2010-02-16 13:37:00-05:00,UTHR,positive
1302454.0,"Stocks That Crossed Their 52-Week Highs (SCSS, SIRI, WRLD, UTHR, WRLS)",2010-02-02 14:42:00-05:00,UTHR,neutral
1302455.0,"Benzinga’s Volume Movers (FFBC, NFLX, GNTX, ALGN, UTHR)",2010-01-28 14:29:00-05:00,UTHR,neutral
1302456.0,"Benzinga’s Volume Movers (FMBI, MAPP, CTEL, BIDU, UTHR)",2010-01-14 15:19:00-05:00,UTHR,neutral
1302457.0,UTHR Best Biotech Stock For 2010,2010-01-13 09:40:00-05:00,UTHR,positive
